Search research articles
Contact Us
Filters
Showing results (31-40 of 93) with videos related to
Page
of 10
Sort By:
The Journal of Infectious Diseases
|
November 23, 2022
Impact of Vaccination, Prior Infection, and Therapy on Omicron Infection and Mortality
Xiaofeng Wang, Joe Zein, Xinge Ji, et al.
Journal of Biotechnology and Biomedicine
|
December 5, 2023
A Cost-Benefit Analysis of Bivalent Covid-19 Vaccines
Dan-Yu Lin, Yangjianchen Xu, Donglin Zeng, et al.
Biometrics
|
April 29, 2016
On confidence intervals for the hazard ratio in randomized clinical trials
Dan-Yu Lin, Luyan Dai, Gang Cheng, et al.
The Lancet. Infectious Diseases
|
March 7, 2024
Effectiveness of XBB.1.5 vaccines and antiviral drugs against severe outcomes of omicron infection in the USA
Dan-Yu Lin, Shuaiqi Huang, Alex Milinovich, et al.
Genetic Epidemiology
|
September 20, 2022
Mediation analysis of multiple mediators with incomplete omics data
John Kidd, Chelsea K Raulerson, Karen L Mohlke, et al.
JAMA Internal Medicine
|
October 27, 2025
Durability of 2024-2025 COVID-19 Vaccines Against JN.1 Subvariants
Yi Du, Sai Paritala, Yangjianchen Xu, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 14, 2015
Integrative analysis of sequencing and array genotype data for discovering disease associations with rare mutations
Yi-Juan Hu, Yun Li, Paul L Auer, et al.
Biometrics
|
March 19, 2016
Simultaneous inference on treatment effects in survival studies with factorial designs
Dan-Yu Lin, Jianjian Gong, Paul Gallo, et al.
BMC Genomics
|
February 16, 2017
PreMeta: a tool to facilitate meta-analysis of rare-variant associations
Zheng-Zheng Tang, Paul Bunn, Ran Tao, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 14, 2021
Evaluating Vaccine Efficacy Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Dan-Yu Lin, Yu Gu, Donglin Zeng, et al.
Page
of 10
Search research articles
Search
Showing results (31-40 of 93) with videos related to
Sort By:
Page
of 10
The Journal of Infectious Diseases
|
November 23, 2022
Impact of Vaccination, Prior Infection, and Therapy on Omicron Infection and Mortality
Xiaofeng Wang, Joe Zein, Xinge Ji, et al.
Journal of Biotechnology and Biomedicine
|
December 5, 2023
A Cost-Benefit Analysis of Bivalent Covid-19 Vaccines
Dan-Yu Lin, Yangjianchen Xu, Donglin Zeng, et al.
Biometrics
|
April 29, 2016
On confidence intervals for the hazard ratio in randomized clinical trials
Dan-Yu Lin, Luyan Dai, Gang Cheng, et al.
The Lancet. Infectious Diseases
|
March 7, 2024
Effectiveness of XBB.1.5 vaccines and antiviral drugs against severe outcomes of omicron infection in the USA
Dan-Yu Lin, Shuaiqi Huang, Alex Milinovich, et al.
Genetic Epidemiology
|
September 20, 2022
Mediation analysis of multiple mediators with incomplete omics data
John Kidd, Chelsea K Raulerson, Karen L Mohlke, et al.
JAMA Internal Medicine
|
October 27, 2025
Durability of 2024-2025 COVID-19 Vaccines Against JN.1 Subvariants
Yi Du, Sai Paritala, Yangjianchen Xu, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 14, 2015
Integrative analysis of sequencing and array genotype data for discovering disease associations with rare mutations
Yi-Juan Hu, Yun Li, Paul L Auer, et al.
Biometrics
|
March 19, 2016
Simultaneous inference on treatment effects in survival studies with factorial designs
Dan-Yu Lin, Jianjian Gong, Paul Gallo, et al.
BMC Genomics
|
February 16, 2017
PreMeta: a tool to facilitate meta-analysis of rare-variant associations
Zheng-Zheng Tang, Paul Bunn, Ran Tao, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 14, 2021
Evaluating Vaccine Efficacy Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Dan-Yu Lin, Yu Gu, Donglin Zeng, et al.
Page
of 10